Myezom 2mg Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Bortezomib (2mg)
Overview Myezom 2mg Injection
Myeloma treatment often involves the 2mg Myzom injection, also effective against mantle cell lymphoma. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administered intravenously by healthcare professionals, dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to prescribed usage; incorrect or excessive administration may lead to severe adverse effects. Therapeutic benefits might not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include tiredness, nausea, vomiting, and decreased appetite. Increased hydration is frequently recommended. Avoid driving or operating machinery due to potential drowsiness and dizziness. Reduced blood cell counts (including red and white cells), raising infection risk, are possible. Regular blood tests monitoring blood cell levels, along with liver, heart, and uric acid levels, are crucial. Pre-existing liver, kidney, heart conditions, or bleeding disorders necessitate prior consultation. Report any cognitive changes, such as memory impairment or difficulty concentrating. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception is essential for both partners throughout treatment.
Primary Ingredients of Myezom 2mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Myezom 2mg Injection
Myeloma and mantle cell lymphoma
Major Benefits of Myezom 2mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Myezom 2mg Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Myezom 2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Myezom 2mg Injection works:
Myezom 2mg Injection is an anticancer agent that inhibits the cellular degradation of proteins. This protein accumulation within cancer cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Myezom 2mg Injection and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Myezom 2mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Myezom 2mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingUNSAFE
Administering Myezom 2mg Injection may induce adverse reactions impacting driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual disturbances, potentially compromising safe driving.
KidneyCAUTION
For individuals with severe kidney impairment, administration of Myezom 2mg Injection requires careful consideration. A modified dosage of Myezom 2mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Myezom 2mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Myezom 2mg Injection :
Omitting a scheduled dose of Myezom 2mg Injection necessitates contacting your physician.
Facts to Know About Myezom 2mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |



